文献速递泌尿生殖技术与安全MRUS

基于双参数MRI的深度学习算法在放疗后前列腺癌局部复发检测中的评估

Evaluation of a Deep Learning-based Algorithm for Post-Radiotherapy Prostate Cancer Local Recurrence Detection Using Biparametric MRI.
PubMed 文献 · Eur J Radiol · 2023-09-13

本研究纳入62例放疗后行多参数MRI及MRI/US融合引导和/或系统活检的患者,以病理为金标准,比较基于双参数MRI的人工智能模型与前瞻性放射科医师评估对局部复发的检测敏感度。AI模型在患者水平和病灶水平的敏感度均低于放射科医师(76.1% vs 91.3%,p=0.02;71.4% vs 87.5%,p=0.01),但在外照射放疗组和腺体体积>34 ml患者中表现较高。作者认为该模型能检出多数放疗后局部复发前列腺癌,临床实施前需进一步外部验证。

要点

  • AI模型患者水平敏感度76.1%,低于放射科医师的91.3%(p=0.02)。
  • AI模型病灶水平敏感度71.4%,低于放射科医师的87.5%(p=0.01)。
  • 外照射放疗组AI敏感度高于近距离治疗组(患者水平81.5% vs 68.4%)。

核心结论

  • 基于双参数MRI的AI模型能检出多数放疗后局部复发前列腺癌,但患者水平和病灶水平敏感度均低于前瞻性放射科医师评估,临床实施前需进一步外部验证。

研究设计与样本

  • 研究纳入62例有放疗史、接受多参数MRI及后续MRI/US融合引导和/或系统活检的患者,以组织病理学结果为金标准,将基于双参数MRI的AI模型(在大型数据集上开发、主要用于识别初治患者病灶)的复发癌检测敏感度与前瞻性放射科医师评估进行比较,采用Wald检验。

诊断标准与关键数值

  • AI模型患者水平敏感度76.1% vs 放射科医师91.3%(p=0.02),病灶水平敏感度71.4% vs 87.5%(p=0.01);AI模型每例患者平均假阳性数0.35(范围0-2);外照射放疗组患者水平敏感度81.5%(22/27)vs 近距离治疗组68.4%(13/19),病灶水平敏感度79.4%(27/34)vs 59.1%(13/22);腺体体积>34 ml患者(n=25)患者水平敏感度100%(11/11)、病灶水平敏感度94.1%(16/17)。

临床应用与阅片要点

  • 作者认为该AI模型能检出多数放疗后局部复发前列腺癌,但临床实施前需进一步外部验证。

局限性

  • 原文结论指出临床实施前需对该模型进行进一步测试,包括外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate a biparametric MRI (bpMRI)-based artificial intelligence (AI) model for the detection of local prostate cancer (PCa) recurrence in patients with radiotherapy history.

MATERIALS AND METHODS: This study included post-radiotherapy patients undergoing multiparametric MRI and subsequent MRI/US fusion-guided and/or systematic biopsy. Histopathology results were used as ground truth. The recurrent cancer detection sensitivity of a bpMRI-based AI model, which was developed on a large dataset to primarily identify lesions in treatment-naïve patients, was compared to a prospective radiologist assessment using the Wald test. Subanalysis was conducted on patients stratified by the treatment modality (external beam radiation treatment [EBRT] and brachytherapy) and the prostate volume quartiles.

RESULTS: Of the 62 patients included (median age = 70 years; median PSA = 3.51 ng/ml; median prostate volume = 27.55 ml), 56 recurrent PCa foci were identified within 46 patients. The AI model detected 40 lesions in 35 patients. The AI model performance was lower than the prospective radiology interpretation (Rad) on a patient-(AI: 76.1% vs. Rad: 91.3%, p = 0.02) and lesion-level (AI: 71.4% vs. Rad: 87.5%, p = 0.01). The mean number of false positives per patient was 0.35 (range: 0-2). The AI model performance was higher in EBRT group both on patient-level (EBRT: 81.5% [22/27] vs. brachytherapy: 68.4% [13/19]) and lesion-level (EBRT: 79.4% [27/34] vs. brachytherapy: 59.1% [13/22]). In patients with gland volumes >34 ml (n = 25), detection sensitivities were 100% (11/11) and 94.1% (16/17) on patient- and lesion-level, respectively.

CONCLUSION: The reported bpMRI-based AI model detected the majority of locally recurrent prostate cancer after radiotherapy. Further testing including external validation of this model is warranted prior to clinical implementation.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Yilmaz EC, Harmon SA, Belue MJ, et al. Evaluation of a Deep Learning-based Algorithm for Post-Radiotherapy Prostate Cancer Local Recurrence Detection Using Biparametric MRI. Eur J Radiol. 2023. PMID: 37717420. doi:10.1016/j.ejrad.2023.111095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。